Announce your event here
PEGS: The Essential Protein Engineering Summit
2018-04-30 to 2018-05-04
Boston, MA, USA
The Essential Protein Engineering Summit is one of the industry’s preeminent events that inspires accelerated biotherapeutic protein drug development. This weeklong event attracts over 2,300 international participants, and features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective. Conference programs include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology, and emerging therapeutics. Learn more at

http://www.pegsummit.com/external link

3rd Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics
2018-05-17 to 2018-05-18
Barcelona, Spain

Key Practical Learning Points of the Summit:

We are pleased to invite you to the 3rd Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled for May 17-18, 2018 in Barcelona, Spain.

This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on:

DISCOVERY, DEVELOPMENT & BIOANALYTICAL STRATEGIES TOWARDS NEXT GENERATION ADC:

SUCCESSFUL TRANSLATION INTO CLINIC & CLINICAL PROGRESS:

ESTABLISHING ROBUST MANUFACTURING SUPPLY CHAINS

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Barcelona in May!

http://vonlanthengroup.com/en/events/3rd-annual-antibody-drug-conjugates-adc-summit-from-target-to-therapeutics.htmlexternal link

3rd Annual Advances in Immuno-Oncology Congress
2018-05-24 to 2018-05-25
London, UK

Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

6 interactive streams:

View the Agenda here: http://bit.ly/2oJlVB7

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

https://www.immunooncology-congress.com/external link

PEGS: Medical Biotechnology
2018-05-24 to 2018-05-25
Ghent, Belgium

With this conference on Medical Biotechnology, VIB will bring together experts in the field to discuss the new developments and future challenges in this field. Four plenary sessions will cover biopharmaceutical technology, targeted delivery, diagnostics & biomarkers and vaccines.

In addition to the scientific sessions there will be ample opportunities to network during the breaks, posters sessions, reception and conference dinner.

https://vibconferences.be/event/medical-biotechnologyexternal link

6th Antibody Industrial Symposium 2018 (AIS2018)
2018-06-25 to 2018-06-26
CORUM Congress Center

The 6th Antibody Industrial Symposium 2018 (AIS2018) congress, organized by the LabEx MAbImprove and MabDesign, offers an ideal conference for scientists, industries, physicians and policy makers to exchange about therapeutic antibodies.

The scientific Committee has set-up an exciting program focusing on the following theme: “Targets for mAbs: Innovative Approaches for their Discovery & Validation”.

The 2 days program includes keynote lectures, pitch talks of new creative projects, industrial talks from pharmaceutical companies and a poster session. Furthermore, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.

The topics covered during this meeting are:

-Validated Targets: lessons learned from success & failure in clinical

-Discovery Approaches: Accessing clinical material, Target Identification platforms, OMICS-based analysis

-New Approaches/Technologies for Discovery & Validation of New Targets for mAbs

-Pre-Clinical Validation: Methods, Models & Companion tests

-Emerging Targets: Immunocheckpoints & Microenvironment

Visit the AIS2018 website to know more and register !:

http://www.aiscongress.comexternal link

Antibodies and complement: Effector functions, therapies and technologies
2018-06-29 to 2018-07-01
Girona, Spain

This 4-day conference will focus attention on key advances in the fields of antibodies, complement and their receptors. 21 invited speakers, 19 oral presentations selected from submitted abstracts, and 2 poster sessions will enable productive exchanges and publicity around your projects and achievements. Attendance is capped at 150. The conference will present recent advances in these exciting fields, in an informal setting designed to maximize interaction. The 4* venue possesses outside pools overseeing the Mediterranean Sea, with direct access to the beach (daily free time slots). >20 travel grants available for students/post-docs.

Topics and Speakers:

2 Keynote Sessions: Paul Parren (U. of Leiden, NL) & George Georgiou (UT Austin, USA)
Novel IgG & complement functions
Structure function relations
Regulation of function & glycosylation
Technological advances
Ab and complement receptors
2 poster sessions with prizes

 

 

http://meetings.embo.org/event/18-antibodiesexternal link